Blueberries Medical Corp.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Blueberries Medical Corp. (CSE: BBM; OTCQB: BBRRF) operates as a fully licensed producer of pharmaceutical-grade cannabis derivatives and related bioactive ingredients in Colombia. The company cultivates, extracts, and supplies medicinal cannabis products, including psychoactive and non-psychoactive derivatives such as CBD isolates, water-soluble CBD specialties, THC extracts, food specialties, magistral formulas, and dried flower; it also distributes functional supplements, wellness products, and natural ingredients derived from plants native to Latin America. Blueberries Medical maintains primary operations in the Bogotá Savannah of central Colombia, with headquarters in Vancouver, Canada, and founded in 2013, serving international markets across healthcare, pharmaceutical manufacturing, and consumer wellness sectors in regions including North America, South America, Europe, and Asia. In March 2025, Blueberries Medical raises C$1.05 million (US$740,000) through a non-brokered private placement led by Terraflos Inc., a company controlled by Chairman and CEO Facundo Garreton, to fund operational expansion, general corporate purposes, and working capital. The company functions as a key operating entity within the Terraflos Inc. ecosystem, focusing on scalable production of high-value bioactives for functional foods, supplements, and skincare via advanced extraction technologies. Blueberries Medical previously enters a joint venture with Allied Corp. in 2023 to produce derivative products for global distribution, enhancing its capabilities in psychoactive and non-psychoactive cannabis extracts.
Blueberries Medical Announces C$1 Million Non-Brokered Private Placement
Blueberries Medical Announces C$1 Million Non-Brokered Private Placement
Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement
Blueberries Medical Announces C$2 Million Non-Brokered Private Placement
Blueberries Medical Announces that its wholly subsidiary Blueberries SAS at Bogota, Colombia has made one of the biggest exports of Premium CBD Full Spectrum Oil of all time, scaling up its business to a level that will improve life condition of more than 2.500 patients in Peru
Blueberries Announces Webcast Instructions for its Annual General and Meeting (“AGM”)
Blueberries Medical Announces Closing of C$ 2.1 Million Non-Brokered Private Placement and the Appointment of New Director
Blueberries Medical Reports 2021 Q2 Financial Results and Provides Corporate and Operations Update
Blueberries Medical Reports 2021 Q1 Financial Results and Provides Corporate and Operations Update
Blueberries Medical Reports 2020 Financial Results
Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay
Blueberries Medical Enters Growing Peruvian Medical Cannabis Market: Enters Binding LOI with Futura Farms
Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations
Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman & Interim CEO
Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project